Stocks
Lannett Company, Inc.LCI
NYSEHealthcareDrug Manufacturers—Specialty & Generic$0.69+0.00%
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing, manufacturing, and distributing generic prescription drugs. The firm primarily serves retail chains, wholesalers, and institutional providers, with investors monitoring its pipeline of cost-effective generic alternatives.
Market Cap: $7.4M52W Range: $0.01 – $3.72
Congressional Interest in Lannett Company, Inc. (LCI)
3 members of Congress have disclosed 5 trades in Lannett Company, Inc. (LCI), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
3
Buys
4
Sells
1
Who in Congress Is Trading LCI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-08-25 | Rohit Khanna | buy | $1K – $15K |
| 2017-05-01 | THOMAS J. ROONEY | sell | $50K – $100K |
| 2016-12-12 | THOMAS J. ROONEY | buy | $15K – $50K |
| 2015-10-16 | KENNY MARCHANT | buy | $1K – $15K |
| 2015-10-15 | KENNY MARCHANT | buy | $1K – $15K |